Asthma and COVID-19: review of evidence on risks and management considerations.

Hartmann-Boyce, Jamie; Gunnell, James; Drake, Jonny; Otunla, Afolarin; Suklan, Jana; Schofield, Ella; Kinton, Jade; Inada-Kim, Matt; Hobbs, F D Richard; Dennison, Paddy

Hartmann-Boyce, Jamie; Gunnell, James; Drake, Jonny; Otunla, Afolarin; Suklan, Jana; Schofield, Ella; Kinton, Jade; Inada-Kim, Matt; Hobbs, F D Richard; Dennison, Paddy.

Afiliação

Hartmann-Boyce J; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK jamie.hartmann-boyce@phc.ox.ac.uk.
Gunnell J; Medical Sciences Division, University of Oxford, Oxford, Oxfordshire, UK.
Drake J; Medical Sciences Division, University of Oxford, Oxford, Oxfordshire, UK.
Otunla A; Medical Sciences Division, University of Oxford, Oxford, Oxfordshire, UK.
Suklan J; Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
Schofield E; Medical Sciences Division, University of Oxford, Oxford, Oxfordshire, UK.
Kinton J; Medical Sciences Division, University of Oxford, Oxford, Oxfordshire, UK.
Inada-Kim M; Royal Hampshire County Hospital, Winchester, Hampshire, UK.
Hobbs FDR; Department of Primary Care Health Sciences, University of Oxford, Oxford, Oxfordshire, UK.
Dennison P; University Hospital Southampton NHS Foundation Trust, Southampton, Southampton, UK.

BMJ Evid Based Med ; 2020 Sep 03.

Article em En | MEDLINE | ID: mdl-32883705

Palavras-chave

respiratory tract diseases; virus diseases

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google